Movement Disorders (revue) - Checkpoint (PascalFrancis)

Index « PascalFr.i » - entrée « Pathologie expérimentale »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Pathologie du tube digestif < Pathologie expérimentale < Paupière  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 41.
[0-20] [0 - 20][0 - 41][20-40]
Ident.Authors (with country if any)Title
000503 (2011) Davide Chiasserini [Italie] ; Alessandro Tozzi [Italie] ; Antonio De Lure [Italie] ; Michela Tantucci [Italie] ; Federica Susta [Italie] ; Pier Luigi Orvietani [Italie] ; Keizo Koya [États-Unis] ; Luciano Binaglia [Italie] ; Paolo Calabresi [Italie]Mortalin Inhibition in Experimental Parkinson's Disease
001451 (2007) Penelope J. Hallett [États-Unis] ; J. M. Brotchie [Canada]Striatal delta opioid receptor binding in experimental models of Parkinson's disease and dyskinesia
002472 (2003) Lance A. Smith [Royaume-Uni] ; Michael J. Jackson ; Matthew J. Hansard ; Eleni Maratos ; Peter JennerEffect of pulsatile administration of Levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: Effect of dose, frequency of administration, and brain exposure
002582 (2002) Ronald K. B. Pearce [Royaume-Uni] ; Lance A. Smith [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Tara Banerji [Royaume-Uni] ; Jorgen Scheel-Krüger [Danemark] ; Peter Jenner [Royaume-Uni]The monoamine reuptake blocker brasofensine reverses akinesia without dyskinesia in MPTP-treated and levodopa-primed common marmosets
002626 (2002) Lance A. Smith [Royaume-Uni] ; Banu C. Tel [Royaume-Uni] ; Michael J. Jackson [Royaume-Uni] ; Matthew J. Hansard [Royaume-Uni] ; Rogelio Braceras [Royaume-Uni] ; Céline Bonhomme [France] ; Claire Chezaubernard [France] ; Susanna Del Signore [France] ; Sarah Rose [Royaume-Uni] ; Peter Jenner [Royaume-Uni]Repeated administration of Piribedil induces less dyskinesia than L-dopa in MPTP-treated common marmosets: A behavioural and biochemical investigation
002911 (2001) Oum-Kaltoum Hassani [France] ; Mireille Mouroux [France] ; Georg Andrees Bohme [France] ; Jean-Marie Stutzmann [France] ; Jean Feger [France]Riluzole reduces hyperactivity of subthalamic neurons induced by unilateral 6-OHDA lesion in the rat brain
002969 (2001) L. Munro-Davies [Royaume-Uni] ; J. Winter [Royaume-Uni] ; T. Z. Aziz [Royaume-Uni] ; J. Stein [Royaume-Uni]Kainate acid lesions of the pedunculopontine region in the normal behaving primate
002C12 (2000) R. G. Geocadin [États-Unis] ; J. Muthuswamy [États-Unis] ; D. L. Sherman [États-Unis] ; N. V. Thakor [États-Unis] ; D. F. Hanley [États-Unis]Early electrophysiological and histologic changes after global Cerebral ischemia in rats
002C25 (2000) S. Palfi [États-Unis] ; L. Leventhal [États-Unis] ; C. G. Goetz [États-Unis] ; P. Hantraye [France] ; B.-Z. Roitberg [États-Unis] ; J. Sramek [États-Unis] ; M. Emborg [États-Unis] ; J. H. Kordower [États-Unis]Delayed onset of progressive dystonia following subacute 3-nitropropionic acid treatment in Cebus apella monkeys
002D01 (1999) B. Henry [Royaume-Uni] ; S. H. Fox [Royaume-Uni] ; D. Peggs [Royaume-Uni] ; A. R. Crossman [Royaume-Uni] ; J. M. Brotchie [Royaume-Uni]The α2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-Parkinsonian actions of L-dopa in the MPTP-lesioned primate model of Parkinson's disease
003128 (1997) L. Rioux [États-Unis] ; P. A. Frohna [États-Unis] ; J. N. Joyce [États-Unis] ; J. S. Schneider [États-Unis]The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys
003379 (1996) P. J. Blanchet [Canada] ; R. Grondin ; P. J. BedardDyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates
003564 (1994) R. J. Vermeulen [Pays-Bas] ; B. Drukarch [Pays-Bas] ; M. C. R. Sahadat ; C. Goosen ; E. C. Wolters [Pays-Bas] ; J. C. Stoof [Pays-Bas]The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys
003592 (1994) D. D. Truong [États-Unis] ; R. R. Matsumoto [États-Unis] ; P. H. Schwartz [États-Unis] ; M. J. Hussong [États-Unis] ; C. G. WasterlainNovel rat cardiac arrest model of posthypoxic myoclonus
003595 (1994) J. D. Belluzzi [États-Unis] ; E. F. Domino ; J. M. May ; K. S. Bankiewicz ; D. A. McafeeN-0923, a selective dopamine D2 receptor agonist, is efficacious in rat and monkey models of Parkinson's disease
003610 (1994) G. E. Borodic [États-Unis] ; R. Ferrante ; L. Bruce Pearce ; K. Smith [États-Unis]Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum A toxin injections
003671 (1993) I. Rektor [France] ; M. Svejdova ; C. Silva-Barrat ; C. MeniniThe cholinergic system-dependent myoclonus of the baboon Papio papio is a reticular reflex myoclonus
003676 (1993) S. B. Blunt [Royaume-Uni] ; P. Jenner [Royaume-Uni] ; C. D. MarsdenSuppressive effect of L-dopa on dopamine cells remaining in the ventral tegmental area of rats previously exposed to the neurotoxin 6-hydroxydopamine
003685 (1993) C. A. Hubbard [États-Unis] ; J. M. TrugmanReversal of reserpine-induced catalepsy by selective D1 and D2 dopamine agonists
003708 (1993) K. T. Finnegan [États-Unis]Neurotoxins and monoamine oxidase inhibition: new aspects
003733 (1993) B. Gomez-Mancilla [Canada] ; R. Boucher ; C. Gagnon ; T. Di Paolo ; R. Markstein ; P. J. BedardEffect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PascalFrancis/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i -k "Pathologie expérimentale" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/PascalFr.i  \
                -Sk "Pathologie expérimentale" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    indexItem
   |index=    PascalFr.i
   |clé=    Pathologie expérimentale
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024